A Clinical Trial for Self-Injurious Behavior
NCT03995966 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2026-02-18
Summary
At least one quarter of the 18 million persons in the US with intellectual and developmental disabilities engage in self-injurious behavior (SIB), which can result in injuries, disfigurement, and loss of function (e.g., blindness). SIB that persists in the absence of social reinforcement has been referred to as automatically maintained SIB (ASIB). Research has shown that the sensitivity of ASIB to disruption by alternative reinforcement is identifiable in a standardized assessment, predicts response to treatment, and provides a quantifiable basis for subtyping ASIB. This research has also identified two subtypes that are highly resistant to behavioral treatment using reinforcement alone, necessitating the use of protective equipment and other procedures to minimize injury. The proposed study is a clinical trial that will allow systematic comparison of the effectiveness of two behavioral treatments targeting treatment-resistant subtypes of ASIB.
Conditions
- Self-Injurious Behavior
Interventions
- BEHAVIORAL
-
Noncontingent Reinforcement (NCR)
This treatment for ASIB is based on reinforcer competition. Noncontingent Reinforcement (NCR) will consist of first conducting a competing stimulus assessment (CSA) to identify stimuli (toys, massagers, etc.) associated with reductions in ASIB and high levels of engagement. Treatment then involves NCR in which alternative sources of reinforcement are made freely available to compete with reinforcement maintaining ASIB. Providing additional sources of reinforcement is thought to decrease ASIB by producing a shift in the allocation of responding toward accessing the newly available reinforcement. Additional, more restrictive components may be added if the competing stimuli (CS) are ineffective in reducing ASIB. These additional components are applied in accordance to the least-restrictive treatment model and include response blocking, response reduction procedures, protective equipment, or mechanical restraint.
- BEHAVIORAL
-
Combination Treatment
Combination Treatment is based on the same principles as NCR, but differs in three ways: 1) It includes three pre-treatment assessments that seek to establish competing stimuli, tasks, and self-control equipment through prompting and reinforcement; ; 2) Intensive training in each of these components is conducted to strengthen skills needed to fully access available reinforcement to compete with ASIB; and 3) Combination treatment is assessed, which includes the noncontingent delivery of competing stimuli and differential reinforcement of alternative behavior to reinforce engagement with competing tasks, and use of alternative self-control equipment. This will increase the amount and vary the sources of alternative reinforcement to more effectively reduce ASIB and self-restraint. Restrictive components may be applied as described for the NCR treatment.
Sponsors & Collaborators
-
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
lead OTHER
Principal Investigators
-
Louis P Hagopian, PhD · Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 4 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-04
- Primary Completion
- 2025-09-09
- Completion
- 2026-08-31
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
NCT02646449 ·Status: COMPLETED ·Phase: PHASE2
-
Expanding Access to mTBI Treatment for Veterans and Service Members With Co-occurring Substance Use
NCT06620900 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders
NCT02968537 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder
NCT00218725 ·Status: COMPLETED ·Phase: PHASE1
-
Valproate for Mood Swings and Alcohol Use Following Head Injury
NCT01760785 ·Status: COMPLETED ·Phase: NA
-
Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo
NCT04466215 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Robot-Assisted Intelligent Rehabilitation Treatment in Patients With AUD
NCT05675553 ·Status: UNKNOWN ·Phase: NA
-
A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder
NCT06648655 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder
NCT07029529 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use Disorder
NCT06807918 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of MK0594 in Patients With Alcohol Dependence (0594-020)
NCT00835718 ·Status: TERMINATED ·Phase: PHASE2
-
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
NCT03667846 ·Status: RECRUITING ·Phase: PHASE2
-
Donepezil and Cognitive Training for Alcohol Use Disorder (AUD)
NCT05042102 ·Status: RECRUITING ·Phase: PHASE2
-
Usefulness of Supportive Text Messages in the Treatment of Depressed Alcoholics
NCT01037868 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder
NCT00316303 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
NCT00498628 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Training in the Treatment of AUD
NCT02664038 ·Status: COMPLETED ·Phase: NA
-
Amplification of Positivity for Alcohol Use
NCT06030154 ·Status: RECRUITING ·Phase: NA
-
A Study of Brenipatide in Participants With Alcohol Use Disorder
NCT07219953 ·Status: RECRUITING ·Phase: PHASE3
-
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
NCT06969937 ·Status: RECRUITING ·Phase: PHASE2
-
Development of a Selective ALDH2 Inhibitor to Treat AUD
NCT04311294 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
NCT07219966 ·Status: RECRUITING ·Phase: PHASE3
-
Study of DCR-AUD in Healthy Volunteers
NCT05021640 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Tirzepatide for Recovery and Alcohol Use Management
NCT06727331 ·Status: RECRUITING ·Phase: PHASE2
-
The Effectiveness of a Smartphone Application in the Treatment of Alcohol Use Disorder
NCT03396887 ·Status: UNKNOWN ·Phase: NA